Black Rock Inc. Eyenovia, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Eyenovia, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,575,418 shares of EYEN stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,575,418

Previous 1,634,593 3.62%

Holding current value

$1.28 Million

Previous $3.4 Million 54.13%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.99 - $2.37 $58,583 - $140,244	-59,175 Reduced 3.62%	1,575,418 $1.56 Million
Q4 2023 Feb 13, 2024	BUY	$1.08 - $2.08 $121,841 - $234,657	112,816 Added 7.41%	1,634,593 $3.4 Million
Q3 2023 Nov 13, 2023	BUY	$1.57 - $2.54 $293,313 - $474,532	186,824 Added 13.99%	1,521,777 $2.53 Million
Q2 2023 Aug 11, 2023	BUY	$2.21 - $5.75 $2.79 Million - $7.25 Million	1,260,966 Added 1704.31%	1,334,953 $3.16 Million
Q1 2023 May 12, 2023	SELL	$1.72 - $3.53 $1,312 - $2,693	-763 Reduced 1.02%	73,987 $261,000

Q4 2022 Feb 13, 2023	BUY	$1.54 - $2.06 $2,830 - $3,786	1,838 Added 2.52%	74,750 $121,000
Q3 2022 Nov 14, 2022	BUY	$1.55 - $2.48 $7,777 - $12,444	5,018 Added 7.39%	72,912 $142,000
Q2 2022 Aug 12, 2022	BUY	$1.71 - $3.26 $13,430 - $25,604	7,854 Added 13.08%	67,894 $132,000
Q1 2022 May 12, 2022	BUY	$2.66 - $3.99 $5,043 - $7,565	1,896 Added 3.26%	60,040 $183,000
Q4 2021 Feb 10, 2022	BUY	$3.5 - $6.58 $8,078 - $15,186	2,308 Added 4.13%	58,144 $233,000
Q3 2021 Nov 09, 2021	SELL	$3.97 - $5.64 $17,543 - $24,923	-4,419 Reduced 7.33%	55,836 $274,000
Q2 2021 Aug 11, 2021	BUY	$4.36 - $5.75 $262,711 - $346,466	60,255 New	60,255 $299,000

Others Institutions Holding EYEN

# of Institutions

Shares Held

7.63M

Call Options Held

22.1K

Put Options Held

9.1K

View Full List

About EYENOVIA, INC.

Ticker EYEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,212,900
Market Cap $27.7M
Description
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...

More about EYEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account